ANI Pharmaceuticals Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -100.0% | +100.0% | +87,369,200.0% | +62.2% | -97.7% | +18.9% | +231.7% | +5,488.8% | -96.6% | +666.8% | -66.7% | +96.7% | -82.4% | +428.7% | +1,207.5% | +86.1% | +36.4% | +68.5% | +37.5% | +14.0% | +2.5% | +0.9% | +3.7% | +46.4% | +53.9% | +26.2% | +43.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -81.4% | +18,234.0% | +8.8% | +15.0% | +10.6% | +284.3% | +62.0% | -7.6% | -13.5% | +38.0% | +15.4% | +37.9% | +30.8% | +37.8% | +72.9% | |
| – | -100.0% | +2,429,100.0% | +7,093.3% | +62.2% | -97.7% | +18.9% | +231.7% | +5,488.8% | -96.6% | +666.8% | -66.7% | +75.3% | -82.5% | -1,882.7% | – | +121.3% | +43.0% | +25.5% | +22.5% | +31.4% | +11.5% | -15.4% | -4.8% | +53.7% | +71.9% | +19.3% | +23.7% | |
| – | -52.8% | +185.8% | +13.5% | +123.5% | -22.9% | +148.2% | -30.1% | -39.8% | +23.2% | +232.3% | -13.4% | +190.2% | +11.3% | -61.8% | -89.9% | +56.4% | +7.3% | +1.1% | +212.1% | +69.7% | +28.7% | -19.2% | -28.9% | +96.3% | +53.6% | +30.0% | +15.9% | |
| – | -23.3% | +96.7% | +36.9% | -23.2% | +31.8% | +32.4% | -1.0% | +130.3% | -38.3% | +37.6% | -4.8% | +4.7% | +17.5% | +17.9% | +99.1% | +9.4% | +18.0% | +31.5% | +13.5% | +39.5% | +26.7% | +16.4% | +29.7% | +51.6% | +17.7% | +66.0% | +27.3% | |
| – | -42.3% | +129.9% | +22.9% | +46.6% | -8.0% | +102.0% | -22.6% | +15.0% | -16.6% | +137.6% | +82.1% | +15.4% | +12.0% | -50.4% | -24.6% | +27.5% | +26.3% | +71.6% | +29.2% | +35.9% | +36.3% | +8.1% | +13.1% | +37.1% | +21.3% | +40.7% | +1.6% | |
| – | – | – | – | – | – | – | – | – | -352.3% | – | – | – | – | – | – | +2,127.8% | +63.5% | -38.6% | +41.1% | +24.8% | -53.8% | -198.0% | – | – | – | -98.8% | +13,809.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | +368.0% | -0.9% | -48.9% | +34.2% | +68.5% | +1,298.7% | +2.9% | +6.3% | +22.6% | -12.1% | -27.1% | +26.1% | +135.3% | -4.0% | -34.7% | +14.0% | |
| – | – | – | – | – | – | – | – | – | -371.7% | – | – | – | – | – | – | +15,280.2% | +12.1% | -60.1% | +88.4% | +22.6% | -84.3% | -922.4% | – | – | – | -211.8% | – | |
| – | – | – | – | – | – | – | – | +85.9% | -1,168,485.4% | – | – | -71.6% | -73.7% | -117.9% | – | -46,940.0% | – | -25.4% | +267.3% | -73.8% | -164.5% | – | – | – | – | -437.6% | – | |
| – | – | – | – | – | – | – | – | – | -371.7% | – | – | – | – | – | – | +9,450.5% | -46.5% | -74.4% | -127.4% | – | -60.7% | -470.0% | – | – | – | -198.6% | – | |
| – | – | – | – | – | – | – | – | – | -310.7% | – | – | – | – | – | – | +220.2% | +64.9% | +42.0% | +1.5% | +20.9% | -12.1% | -53.7% | -88.9% | +703.6% | +325.7% | -40.8% | +228.4% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.